Effect of antibiotics on vulvovaginal candidiasis: A metronet study

Journal of the American Board of Family Medicine

Volumn 21, Issue 4, 2008, Pages 261-268

  Xu, Jinping ^a   Schwartz, Kendra ^a   Bartoces, Monina ^a   Monsur, Joseph ^a   Severson, Richard K ^a   Sobel, Jack D ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CANDIDA ALBICANS; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFECT; FAMILY MEDICINE; FEMALE; FOLLOW UP; FUNGUS CULTURE; FUNGUS IDENTIFICATION; HUMAN; INFECTION RATE; INFECTION RISK; MAJOR CLINICAL STUDY; PILOT STUDY; PREDICTION; SHORT COURSE THERAPY; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; UPPER RESPIRATORY TRACT INFECTION; VAGINA CANDIDIASIS;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CANDIDA; CANDIDIASIS, VULVOVAGINAL; COLONY COUNT, MICROBIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MIDDLE AGED; PREVALENCE; TREATMENT OUTCOME; UNITED STATES;

EID: 47749141127     PISSN: 15572625     EISSN: 15587118     Source Type: Journal    
DOI: 10.3122/jabfm.2008.04.070169     Document Type: Article

References (43)

1. Foxman B, Marsh JV, Gillespie B, Sobel JD. Frequency and response to vaginal symptoms among white and African American women: results of a random digit dialing survey. J Womens Health 1998; 7:1167-74.
2. Reed BD. Risk factors for Candida vulvovaginitis. Obstet Gynecol Surv 1992;47:551-60.
3. Monif GR. Classification and pathogenesis of vulvo-vaginal candidiasis. Am J Obstet Gynecol 1985;152(7 Pt 2):935-9.
4. Sobel JD, Faro S, Force RW, et al. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am J Obstet Gynecol 1998;178: 203-11.
5. Weisberg M. Considerations in therapy for vulvo-vaginal candidiasis: when and whom to treat. In: Sobel J, ed. Clinical perspectives: terconazole, an advance in vulvovaginal candidiasis therapy. Vol 51. New York: McGraw-Hill;1988:1-8.
6. Sobel JD. Vulvovaginitis in healthy women. Compr Ther 1999;25:335-46.
7. Xu J, Sobel JD. Antibiotic-associated vulvovaginal Candidiasis. Curr Infect Dis Rep 2003;5:481-7.
8. Ferrer J. Vaginal candidosis: epidemiological and etiological factors. Int J Gynaecol Obstet 2000; 71(Suppl 1):S21-7.
9. Eschenbach D. Lower genital tract infections. In: Galask R, ed. Infectious diseases in the female patient. New York: Springer-Verlag; 1986:163-86.
10. Spinillo A, Capuzzo E, Acciano S, De Santolo A, Zara F. Effect of antibiotic use on the prevalence of symptomatic vulvovaginal candidiasis. Am J Obstet Gynecol 1999;180(1 Pt 1):14-7.
11. Willmott FE. Genital yeasts in female patients attending a VD clinic. Br J Vener Dis 1975;51:119-24.
12. Davis BA. Vaginal moniliasis in private practice. Obstet Gynecol 1969;34:40-5.
13. Leegaard M. The incidence of Candida albicans in the vagina of "healthy young women." How often do they have symptoms? Possible etiological factors. Acta Obstet Gynecol Scand 1984;63:85-9.
14. Hart G. Factors associated with trichomoniasis, candidiasis and bacterial vaginosis. Int J STD AIDS 1993;4:21-5.
15. Iravani A, Richard GA. Amoxicillin-clavulanic acid versus cefaclor in the treatment of urinary tract infections and their effects on the urogenital and rectal flora. Antimicrob Agents Chemother 1986;29:107-11.
16. Miettinen A, Laine S, Teisala K, Heinonen PK. The effect of ciprofloxacin and doxycycline plus metronidazole on lower genital tract flora in patients with proven pelvic inflammatory disease. Arch Gynecol Obstet 1991;249:95-101.
17. Fine JS, Jacobson MS. Single-dose versus conventional therapy of urinary tract infections in female adolescents. Pediatrics 1985;75:916-20.
18. Leigh DA, Joy GE, Tait S, Harris K, Walsh B. Treatment of acute uncomplicated urinary tract infections with single daily doses of cefuroxime axetil. J Antimicrob Chemother 1989;23:267-73.
19. Geiger AM, Foxman B. Risk factors for vulvovaginal candidiasis: a case-control study among university students. Epidemiology 1996;7:182-7.
20. Reed BD, Huck W, Zazove P. Differentiation of Gardnerella vaginalis, Candida albicans, and Trichomonas vaginalis infections of the vagina. J Fam Pract 1989;28:673-80.
21. Spinillo A, Capuzzo E, Nicola S, Baltaro F, Ferrari A, Monaco A. The impact of oral contraception on vul-vovaginal candidiasis. Contraception 1995;51:293-7.
22. Glover DD, Larsen B. Longitudinal investigation of candida vaginitis in pregnancy: role of superimposed antibiotic use. Obstet Gynecol 1998;91:115-8.
23. Rylander E, Berglund AL, Krassny C, Petrini B. Vulvovaginal candida in a young sexually active population: prevalence and association with oro-genital sex and frequent pain at intercourse. Sex Transm Infect. 2004;80:54-7.
24. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991;29:297-301.
25. Tabrizi SN, Pirotta MV, Rudland E, Garland SM. Detection of Candida species by PCR in self-collected vaginal swabs of women after taking antibiotics. Mycoses 2006;49:523-4.
26. Preisser JS, Koch GG. Categorical data analysis in public health. Annu Rev Public Health 1997;18:51-82.
27. Mehta CR, Patel NR. Exact logistic regression: theory and examples. Stat Med 1995;14:2143-60.
28. Odds FC. Genital candidosis. Clin Exp Dermatol 1982;7:345-54.
29. Lindner JG, Plantema FH, Hoogkamp-Korstanje JA. Quantitative studies of the vaginal flora of healthy women and of obstetric and gynaecological patients. J Med Microbiol 1978;11:233-41.
30. Sobel JD. Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Am J Obstet Gynecol 1985;152(7 Pt 2):924-35.
31. Bluestein D, Rutledge C, Lumsden L. Predicting the occurrence of antibiotic-induced candidal vaginitis (AICV). Fam Pract Res J 1991;11:319-26.
32. Beigi RH, Meyn LA, Moore DM, Krohn MA, Hillier SL. Vaginal yeast colonization in nonpregnant women: a longitudinal study. Obstet Gynecol 2004; 104(5 Pt 1):926-30.
33. de Leon EM, Jacober SJ, Sobel JD, Foxman B. Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes. BMC Infect Dis 2002;2:1.
34. Pirotta M, Gunn J, Chondros P, et al. Effect of lactobacillus in preventing post-antibiotic vulvovaginal candidiasis: a randomised controlled trial. BMJ 2004;329:548.
35. MacDonald TM, Beardon PH, McGilchrist MM, Duncan ID, McKendrick AD, McDevitt DG. The risks of symptomatic vaginal candidiasis after oral antibiotic therapy. Q J Med 1993;86:419-24.
36. Caruso L. Vaginal moniliasis after tetracycline therapy. Am J Obstet Gynec 1964;90:374-80.
37. Oriel JD, Waterworth PM. Effects of minocycline and tetracycline on the vaginal yeast flora. J Clin Pathol 1975;28:403-6.
38. Sobel JD. Vaginitis. N Engl J Med 1997;337:1896-903.
39. Berg AO, Heidrich FE, Fihn SD, et al. Establishing the cause of genitourinary symptoms in women in a family practice. Comparison of clinical examination and comprehensive microbiology. JAMA 1984;251: 620-5.
40. Bergman JJ, Berg AO. How useful are symptoms in the diagnosis of Candida vaginitis? J Fam Pract 1983; 16:509-11.
41. Blake DR, Duggan A, Quinn T, Zenilman J, Joffe A. Evaluation of vaginal infections in adolescent women: can it be done without a speculum? Pediatrics 1998;102(4 Pt 1):939-44.
42. Boskey ER, Atherly-Trim SA, O'Campo PJ, Strobino DM, Misra DP. Acceptability of a self-sampling technique to collect vaginal smears for gram stain diagnosis of bacterial vaginosis. Womens Health Issues 2004;14:14-8.
43. Ferris DG, Francis SL, Dickman ED, Miler-Miles K, Waller JL, McClendon N. Variability of vaginal pH determination by patients and clinicians. J Am Board Fam Med 2006;19:368-73.